LENSAR
LNSR | NASDAQ
$5.29
+$0.29 (+5.80%)
At close: Nov 16, 2026, 4:00 PM ET
$5.29
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
+5.80%
(1D)No price chart data available for 1D timeframe.
Rating
51
Fundamentals Strong
Market Sentiment Neutral
Moat Narrow
Sector Rank #259/1021 (Top 25%)
Key Statistics
Market Data
Market Cap $65.04M
1D Range
5.06 5.41
52W Range
4.58 12.73
Valuation (TTM)
PE -13.22
PB 5.88
EV/EBITDA 1.54
Valuation (NTM)
Forward PE 546.00
Forward PEG -0.04
Price Target $11.00
Cash Flow
FCF Yield -7.4%
SBC Adj. FCF Yield -10.6%
SBC Impact -43.2%
Margins
Gross Margin 52.0%
Operating Margin -3.3%
FCF Margin -8.0%
Growth (CAGR)
Revenue 3Y | 5Y 14.3% |
13.8%
Dil EPS 3Y | 5Y 25.4% |
2.1%
FCF 3Y | 5Y 11.7% |
15.3%
Returns
ROA 50.2%
ROE 549.4%
ROIC -4.1%
Financial Health
Net Cash
$12.62M
Current Ratio 2.25
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically i...
Sector Healthcare
Industry Medical - Devices
Employees 150
IPO Date Oct 2, 2020
Website www.lensar.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 10, 2026
EPS
-$0.38
Miss -300.00%
YoY:
-22.58% REV
$14.13M
Miss -1.18%
YoY:
-1.29%Next Earnings
Mar 9, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$11.00
Upside
+107.94%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove LNSR